Putting the Tech in Biotech

A Deep Dive on AI in the Sector

In this inaugural episode of Biotech Breakthroughs, equity research group head Tim Lugo speaks about the impact of artificial intelligence and machine learning on the biotechnology industry, including the ways in which AI is revolutionizing drug development, impacting valuations, and the potential risks that lie ahead.


Recent Papers

Previous
Previous

Vanity Metrics & Black Boxes ≠Therapeutics

Next
Next

BARDA - TechWatch Meeting